FTC Sues Hims & Hers Over Alleged Sharing of Patient Data with Advertisers

The Federal Trade Commission (FTC) has initiated legal action against Hims & Hers, a prominent telehealth provider, alleging that the company shared sensitive patient medical information with major advertisers, including Meta and Snap, without proper consent. This lawsuit underscores the FTC’s ongoing efforts to enforce privacy standards within the healthcare sector.

Hims & Hers offers a range of services, including prescription medications for sexual health, mental health, and weight management, thereby handling a substantial amount of confidential patient data. The FTC’s complaint, filed in a California federal court, asserts that the company embedded tracking tools from Meta, Snap, and other tech firms into its website. These tools reportedly collected and transmitted users’ health-related information, actions that contradict the company’s stated privacy policies.

Additionally, the FTC accuses Hims & Hers of engaging in deceptive billing practices and implementing policies that complicate the cancellation process for consumers, potentially violating federal consumer protection laws.

In response, Hims & Hers issued a statement expressing confidence in its privacy practices and indicating plans to contest the FTC’s allegations. The company emphasized that its privacy policy allows users to control how their data is utilized.

This case is part of a broader pattern of FTC enforcement actions targeting healthcare companies for improper data sharing. Previous actions include settlements with BetterHelp, which was fined $7.8 million for sharing health data with advertisers, and GoodRx, which faced a $1.5 million penalty for similar violations. These cases highlight the FTC’s commitment to safeguarding consumer health information in the digital age.

The use of tracking technologies by healthcare providers raises significant privacy concerns, as these tools can inadvertently expose sensitive patient data to third parties. This lawsuit serves as a critical reminder for companies handling health information to rigorously adhere to privacy policies and ensure transparent data practices to maintain consumer trust and comply with regulatory standards.